New York – United States
Data Bridge Market Research analyses that the Infertility Treatment Market is expected to undergo a CAGR of 8.03% during the forecast period. This indicates that the market value, which was USD 1.50 billion in 2021, would rocket up to USD 2.78 billion by 2029.
“Assisted Reproductive Technology (ART)” dominates the application segment of the infertility treatment market owing to the increasing number of technological advancements, growing awareness about assisted reproductive technology (ART) and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Infertility is a prevailing issue all around the globe. According to a recent report, 25% of the women with fertility issue suffer irregular ovulation. Smoking populations has shown symptoms of decreased fertility. All of this has induced funds towards research and development activities to understand the reasons and develop drugs for the treatment.
Download an Exclusive Sample Report @
From the name itself, it is clear that infertility treatment is the treatment options available to treat an individual suffering from infertility. Infertility is a medical condition of an individual’s inability to reproduce owing to the dearth of fertile semen. Infertility occurs due to various reasons, however, this doesn’t mean that it cannot be treated or there are any dearth of alternatives.
Some of the major players operating in the infertility treatment market are The Cooper Companies Inc. (US), Cook (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), Carl Zeiss AG (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US) among others.
Recent Development
- In 2021, CooperSurgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.
- In 2021, Hamilton Thorne Ltd. received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
- In 2020, Genea Biomedx (Australia) collaborated with Hamilton Thorne to commercialize Genea Biomedx’s (Australia) fertility products in the US and Canada.
Get a Comprehensive Understanding of This Research Report @
https://www.databridgemarketresearch.com/reports/global-infertility-treatment-market?dv
Global Infertility Treatment Market Scope
The infertility treatment market is segmented on the basis of sex, diagnosis, drugs and techniques. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Sex
- Males
- Females
- Unexplained
Based on the sex, the infertility treatment market is segmented into males, females and unexplained.
Diagnosis
- Men Diagnostic Tests
- Women Diagnostic
- General Diagnostic Tests
Based on the diagnosis, the infertility treatment market is segmented into men diagnostic tests, women diagnostic tests, and general diagnostic tests. Men diagnostic tests is further sub segmented into semen analysis, genetic testing, testicular biopsy, and other. Women diagnostic tests is further sub segmented into hysteroscopy, laparoscopy, ovulation testing, hysterosalpingography and others. General diagnostic tests is further sub segmented into genetic testing, hormone testing, microscopic analysis, imaging, and others.
Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others
Based on the drugs, the infertility treatment market is segmented into clomiphene citrate, letrozole, serophene, hormone treatment and others.
Techniques
- Assisted Reproductive Technology (ART)
- Intrauterine Insemination
- Surgery
Based on the techniques, the infertility treatment market is segmented into assisted reproductive technology (ART), intrauterine insemination, and surgery. Surgery is further sub segmented into laparoscopic or hysteroscopic surgery, tubal surgeries and others.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience, which was formulated and framed in the year 2015 in Pune.
Media Contact
Sopan Gedam
Organization: Data Bridge Market Research
Phone: +1-888-387-2818
Email: sales@databridgemarketresearch.com
Web: www.databridgemarketresearch.com